SG11202101919VA - Manufacturing method for 4-methoxypyrrole derivatives - Google Patents

Manufacturing method for 4-methoxypyrrole derivatives

Info

Publication number
SG11202101919VA
SG11202101919VA SG11202101919VA SG11202101919VA SG11202101919VA SG 11202101919V A SG11202101919V A SG 11202101919VA SG 11202101919V A SG11202101919V A SG 11202101919VA SG 11202101919V A SG11202101919V A SG 11202101919VA SG 11202101919V A SG11202101919V A SG 11202101919VA
Authority
SG
Singapore
Prior art keywords
manufacturing
methoxypyrrole derivatives
methoxypyrrole
derivatives
Prior art date
Application number
SG11202101919VA
Inventor
Jeong Taek Shin
Jeong Hyun Son
Deok Ki Eom
Original Assignee
Daewoong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co Ltd filed Critical Daewoong Pharmaceutical Co Ltd
Priority claimed from PCT/KR2019/012122 external-priority patent/WO2020060213A1/en
Publication of SG11202101919VA publication Critical patent/SG11202101919VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
SG11202101919VA 2018-09-19 2019-09-19 Manufacturing method for 4-methoxypyrrole derivatives SG11202101919VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180112196 2018-09-19
KR1020190110997A KR102126576B1 (en) 2018-09-19 2019-09-06 Manufacturing method for 4-methoxypyrrole derivatives
PCT/KR2019/012122 WO2020060213A1 (en) 2018-09-19 2019-09-19 Method for producing 4-methoxy pyrrole derivative

Publications (1)

Publication Number Publication Date
SG11202101919VA true SG11202101919VA (en) 2021-04-29

Family

ID=69959291

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202101919VA SG11202101919VA (en) 2018-09-19 2019-09-19 Manufacturing method for 4-methoxypyrrole derivatives

Country Status (21)

Country Link
US (1) US20210221770A1 (en)
EP (1) EP3854784A4 (en)
JP (1) JP7253624B2 (en)
KR (1) KR102126576B1 (en)
CN (1) CN112739684A (en)
AU (1) AU2019343857B2 (en)
BR (1) BR112021005156A2 (en)
CA (1) CA3110830A1 (en)
CL (1) CL2021000639A1 (en)
CO (1) CO2021003195A2 (en)
DO (1) DOP2021000042A (en)
EC (1) ECSP21019076A (en)
JO (1) JOP20210040A1 (en)
MA (1) MA53673A (en)
MX (1) MX2021003137A (en)
NZ (1) NZ773997A (en)
PE (1) PE20211736A1 (en)
PH (1) PH12021550523A1 (en)
RU (1) RU2763287C1 (en)
SG (1) SG11202101919VA (en)
TN (1) TN2021000035A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102081920B1 (en) 2016-03-25 2020-02-26 주식회사 대웅제약 Novel crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine salt
KR102233455B1 (en) * 2017-06-21 2021-03-29 주식회사 대웅제약 Method for preparation of intermediate of 4-methoxypyrrole derivative
TW202241409A (en) 2020-12-18 2022-11-01 南韓商大熊製藥股份有限公司 New formulation comprising 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine for the oral administration
KR102556500B1 (en) * 2021-11-19 2023-07-19 하나제약 주식회사 Pyrrole derivatives or pharmaceutically or food acceptable salts thereof, and composition for preventing, improving or treating gastrointestinal diseases comprising the same as an active ingredient
WO2023229323A1 (en) * 2022-05-23 2023-11-30 일동제약(주) Method for preparing 6-methoxypyridin-3-yl derivative
WO2023229322A1 (en) * 2022-05-23 2023-11-30 일동제약(주) Method for preparing 6-methoxypyridin-3-yl derivatives
CN117820193A (en) * 2022-09-29 2024-04-05 安徽皓元药业有限公司 non-Su Lazan hydrochloride crystal form A and preparation method thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1803709B1 (en) * 2004-09-30 2013-01-02 Takeda Pharmaceutical Company Limited Proton pump inhibitors
US7994205B2 (en) * 2006-03-31 2011-08-09 Takeda Pharmaceutical Company Limited Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors
US8933105B2 (en) * 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
JP6292736B2 (en) * 2012-11-19 2018-03-14 ジエンス ハンセン ファーマセウティカル カンパニー リミテッド Pyrrolesulfonamide derivative, its production method and its medical use
JP2017071553A (en) * 2014-02-25 2017-04-13 味の素株式会社 Novel compound having hetero atom-methylene-heterocycle structure
CN104447491B (en) * 2014-11-19 2017-06-23 连云港恒运医药有限公司 Hemifumarate and its intermediate and medical usage containing pyrrole ring proton pump inhibitor
KR101613245B1 (en) * 2015-04-27 2016-04-18 주식회사 대웅제약 Novel 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same
CN106432191A (en) * 2015-08-10 2017-02-22 陕西合成药业股份有限公司 Novel pyrroles derivative as well as preparation method and pharmaceutical application thereof
KR102081920B1 (en) * 2016-03-25 2020-02-26 주식회사 대웅제약 Novel crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine salt
WO2017164575A1 (en) * 2016-03-25 2017-09-28 Daewoong Pharmaceutical Co.,Ltd. Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine
CN107879964B (en) * 2016-09-29 2023-02-10 江苏柯菲平医药股份有限公司 Preparation method of 1- (5- (2-fluorophenyl) -1- (3- (3-methoxy propoxy) benzenesulfonyl chloride) -1H-pyrrole-3-yl) -N-methylamine
CN108503621B (en) * 2017-12-25 2021-09-14 上海中拓医药科技有限公司 Preparation method of vonoprazan fumarate

Also Published As

Publication number Publication date
TN2021000035A1 (en) 2022-10-03
EP3854784A1 (en) 2021-07-28
MA53673A (en) 2022-03-30
CL2021000639A1 (en) 2021-08-06
JOP20210040A1 (en) 2021-03-07
PH12021550523A1 (en) 2022-02-21
PE20211736A1 (en) 2021-09-06
AU2019343857B2 (en) 2021-12-02
CN112739684A (en) 2021-04-30
BR112021005156A2 (en) 2021-06-15
CA3110830A1 (en) 2020-03-26
RU2763287C1 (en) 2021-12-28
JP7253624B2 (en) 2023-04-06
JP2021535934A (en) 2021-12-23
EP3854784A4 (en) 2022-03-30
NZ773997A (en) 2024-03-22
KR102126576B1 (en) 2020-06-24
AU2019343857A1 (en) 2021-04-15
ECSP21019076A (en) 2021-05-31
MX2021003137A (en) 2021-05-14
DOP2021000042A (en) 2021-05-31
KR20200033178A (en) 2020-03-27
CO2021003195A2 (en) 2021-04-08
US20210221770A1 (en) 2021-07-22

Similar Documents

Publication Publication Date Title
SG11202101919VA (en) Manufacturing method for 4-methoxypyrrole derivatives
GB201800298D0 (en) Method
IL283331A (en) Method for preparing n-phenylpyrazole-1-carboxamides
EP4046129C0 (en) Manufacturing method
GB201800558D0 (en) Method
IL271024A (en) Method for manufacturing cement
EP3677548A4 (en) Method for manufacturing ultra-porous nano-sio2
ZA202109841B (en) Method for manufacturing mortar-based elements
PL3733651T3 (en) Method for producing calcobutrol
GB201804277D0 (en) Method
SG11201908162RA (en) Method for manufacturing wafer
SG11202007901YA (en) Method for manufacturing instant noodles
GB201803750D0 (en) Method
IL279070A (en) Method for producing diarylpyridine derivatives
IL282108A (en) Preparation method for efinaconazole
SG11202103673UA (en) Method for producing perfluorocycloalkene compound
SG11202005507SA (en) Method for manufacturing methionine
EP3550058A4 (en) Method for manufacturing structure
GB201803183D0 (en) Method
GB201802653D0 (en) Method
GB201801169D0 (en) Method
GB201800187D0 (en) Method
EP4053288A4 (en) Improved method for manufacturing allulose
GB201820302D0 (en) Manufacturing method
GB2588550B (en) Method for manufacturing custom products